Safety of zoster vaccine in elderly adults following documented herpes zoster

Journal of Infectious Diseases

Volumn 208, Issue 4, 2013, Pages 559-563

  Morrison, Vicki A ^a,f   Oxman, Michael N ^b   Levin, Myron J ^c   Schmader, Kenneth E ^d   Guatelli, John C ^b   Betts, Robert F ^e   Gelb, Larry D ^f   Pachucki, Constance T ^f   Keay, Susan K ^g   Menzies, Barbara ^f   Griffin, Marie R ^h   Kauffman, Carol A ⁱ   Marques, Adriana R ^j   Toney, John F ^f   Simberkoff, Michael S ^k   Serrao, Richard ^l   Arbeit, Robert D ^l   Gnann, John W ^m   Greenberg, Richard N ⁿ   Holodniy, Mark ^o   Keitel, Wendy A ^p   Yeh, Shingshing S ^f   Davis, Larry E ^q   Crawford, George E ^r   Neuzil, Kathy M ^f   Johnson, Gary R ^s   Zhang, Jane H ^s   Harbecke, Rith ^b   Chan, Ivan S F ^t   Keller, Paul M ^t   Williams, Heather M ^b   Boardman, Kathy D ^u   Silber, Jeffrey L ^t   Annunziato, Paula W ^t   more..

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF ROCHESTER   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^j NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^k NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l BOSTON UNIVERSITY   (United States)

^m UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁿ LEXINGTON VA MEDICAL CENTER   (United States)

^o VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^p BAYLOR COLLEGE OF MEDICINE   (United States)

^q VA Medical Center   (United States)

^r UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^s DEPARTMENT OF VETERANS AFFAIRS   (United States)

^t MERCK RESEARCH LABORATORIES   (United States)

^u VA Cooperative Studies Program Clinical Research Pharmacy   (United States)

more..

Author keywords

ACIP recommendations; Herpes zoster; Zoster vaccine; Zoster vaccine in elderly persons; Zoster vaccine safety

Indexed keywords

VARICELLA ZOSTER VACCINE;

ACUTE DISEASE; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BLOOD CLOTTING DISORDER; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; EYE DISEASE; FAINTNESS; FATIGUE; FEVER; FOLLOW UP; HEARING IMPAIRMENT; HEART INFARCTION; HERPES ZOSTER; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MEDICAL HISTORY; NAUSEA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; VACCINATION; VERTIGO; VOMITING;

ACIP RECOMMENDATIONS; HERPES ZOSTER; ZOSTER VACCINE; ZOSTER VACCINE IN ELDERLY PERSONS; ZOSTER VACCINE SAFETY;

AGED; AGED, 80 AND OVER; DRUG TOXICITY; FEMALE; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; MALE; MIDDLE AGED;

EID: 84880406511     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit182     Document Type: Article

References (9)

1. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-84.
2. Oxman MN. Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology 1995; 45(Suppl 8):S41-6.
3. Levin MJ, Oxman MN, Zhang JH, et al. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis 2008; 197:825-35.
4. Weinberg A, Zhang JH, Oxman MN, et al. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis 2009; 200:1068-77.
5. Baylor NW. May 25, 2006 Approval Letter - Zostavax. Updated 16 February 2010. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/Approved Products/htm. Accessed 2 May 2013.
6. Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008; 57(RR-5):1-30; quiz CE2-4.
7. Mills R, Tyring SK, Levin MJ, et al. Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster. Vaccine 2010; 28:4204-9.
8. Harbecke R, Oxman MN, Arnold BA, et al. A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. J Med Virol 2009; 81: 1310-22.
9. Simberkoff MS, Arbeit RD, Johnson GR, et al. Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial. Ann Intern Med 2010; 152:545-54.